Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5414/cnp58073 http://scihub22266oqcxt.onion/10.5414/cnp58073 12141411!?!12141411 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12141411&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Clin+Nephrol 2002 ; 58 (1): 73-6 Nephropedia Template TP {{tp|p=12141411|t=2002. Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman s syndrome |pdf=|usr=}}{{12141411}} gab.com Text Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman s syndrome JO: Clin Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=12141411 #FOAvip Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism. Hypokalemia can at times be refractory to treatment. We present a patient refractory to a variety of drugs including indomethacin, the nonspecific COX inhibitor. Rofecoxib, a specific COX 2 inhibitor, promptly elevated serum potassium concentration with normalization of plasma aldosterone and near normalization of renin without a change in serum magnesium. Our patient also had rhabdomyolysis, a rarely reported complication, which was also ameliorated by COX 2 inhibition. Twit Text FOAVip Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman s syndrome ????Clin Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=12141411 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=12141411 #FOAvip English Wikipedia <ref>{{Cite pmid|12141411}}</ref> Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman s syndrome #MMPMID12141411 Mayan H; Gurevitz O; Farfel Z Clin Nephrol 2002[Jul]; 58 (1): 73-6 PMID12141411show ga Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism. Hypokalemia can at times be refractory to treatment. We present a patient refractory to a variety of drugs including indomethacin, the nonspecific COX inhibitor. Rofecoxib, a specific COX 2 inhibitor, promptly elevated serum potassium concentration with normalization of plasma aldosterone and near normalization of renin without a change in serum magnesium. Our patient also had rhabdomyolysis, a rarely reported complication, which was also ameliorated by COX 2 inhibition. |Adult[MESH] |Alkalosis/drug therapy[MESH] |Calcium/urine[MESH] |Cyclooxygenase Inhibitors/*therapeutic use[MESH] |Humans[MESH] |Hyperaldosteronism[MESH] |Hypokalemia/diagnosis/*drug therapy[MESH] |Lactones/*therapeutic use[MESH] |Magnesium/blood[MESH] |Male[MESH] |Rhabdomyolysis/diagnosis/*drug therapy[MESH] |Sulfones[MESH] |Syndrome[MESH]Successful treatment by cyclooxyenase-2 inhibitor of refractory hypoka(epmc).pdf DeepDyve Pubget Overpricing